Ling W Chen

US Patent:

7406090, Jul 29, 2008

Filed:

Jun 30, 2003

Appl. No.:

10/611616

Inventors:

Ling Chen - Livingston NJ, US

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

G06F 12/00
G06F 13/00
H04L 12/54
H04J 3/06

US Classification:

370412, 3703954, 370413, 370415, 370417, 370419, 370428, 370509, 370512, 711147, 3794061

Abstract:

A method and apparatus to perform buffer management for media processing are described.

US Patent:

7865634, Jan 4, 2011

Filed:

Jun 30, 2008

Appl. No.:

12/164902

Inventors:

Ling Chen - Livingston NJ, US

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

G06F 12/00
G06F 13/00
H04L 12/54
H04J 3/06

US Classification:

710 52, 710 54, 710 55, 711147, 3703954, 370412, 370413, 370415, 370417, 370419, 370428, 370509, 370512, 3794061

Abstract:

A method and apparatus to perform buffer management for media processing are described.

US Patent:

8017733, Sep 13, 2011

Filed:

Jul 16, 2004

Appl. No.:

10/892830

Inventors:

KoChung Lin - Lexington MA, US
R. Blake Pepinsky - Arlington MA, US
Ling Ling Chen - Wellesley MA, US
Donna M. Hess - Waltham MA, US
Edward Y. Lin - Somerville MA, US
Russell C. Petter - Stow MA, US
Darren P. Baker - Hingham MA, US

Assignee:

Biogen Idec MA Inc. - Cambridge MA

International Classification:

C07K 17/08
C07K 14/565
C11D 3/38
C08G 59/00
C08G 59/14
C11D 3/386

US Classification:

530351, 435 6951, 436 86, 510320, 525525, 525526

Abstract:

The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.

US Patent:

8524660, Sep 3, 2013

Filed:

Sep 12, 2011

Appl. No.:

13/230080

Inventors:

KoChung Lin - Lexington MA, US
R. Blake Pepinsky - Arlington MA, US
Ling Ling Chen - Wellesley MA, US
Donna M. Hess - Waltham MA, US
Edward Y. Lin - Somerville MA, US
Russell C. Petter - Stow MA, US
Darren P. Baker - Hingham MA, US

Assignee:

Biogen Idec MA Inc. - Cambridge MA

International Classification:

A61K 47/48
C08G 65/329
A61K 38/00
C07K 17/08
A61K 31/00
A61K 38/21
C07K 14/565
C12N 15/22

US Classification:

514 43, 514 179, 514 37, 514 23, 514 11, 514 1, 435 6951, 436 86, 510320, 525525, 525526, 530351

Abstract:

The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.

US Patent:

20030204551, Oct 30, 2003

Filed:

Apr 30, 2002

Appl. No.:

10/134760

Inventors:

Ling Chen - Livingston NJ, US

International Classification:

G06F009/00

US Classification:

709/102000

Abstract:

A system for providing a plurality of media processing services includes a processor and a computer-readable medium. The computer-readable medium has stored thereon a set of instructions to be executed by the processor to control multiple media processing services as separate state machines, with the same set of instructions controlling each of the media processing services.

US Patent:

20040010330, Jan 15, 2004

Filed:

Jul 11, 2002

Appl. No.:

10/192547

Inventors:

Ling Chen - Livingston NJ, US

International Classification:

G06F017/00

US Classification:

700/094000

Abstract:

A method for providing playback speed control of digital audio frames for multiple time slots over multiple of channels includes determining a maximum number of frames that can be processed during each of the time slots for all of the channels. The method further includes calculating a speed change determination for each time slot, the speed change determination specifying a total amount of frames that are processed during the time slots in order to achieve a desired speed change. The method further includes tracking an overload for each of the time slots as each of the channels is processed; and, as each of the channels are processed and for each time slot, generating a number of frames that is substantially equal to the speed determination for each time slot if the overload is substantially less than the determined maximum number of frames, or generating a number of frames as if no desired speed change is requested if the overhead is substantially greater than the determined maximum number of frames.

US Patent:

62076485, Mar 27, 2001

Filed:

Jul 17, 1998

Appl. No.:

9/118179

Inventors:

David J. Waxman - Newton MA
Ling Chen - Blue Bell PA

Assignee:

Trustees of Boston University - Boston MA

International Classification:

A01N43/04
7
C12N15/00
15/63
7
C07H21/04

US Classification:

514 44

Abstract:

Methods of killing neoplastic cells are provided. The invention relates to the use of NADPH-cytochrome P450 reductase (RED) gene transfer in combination with cytochrome P450 gene transfer to enhance the sensitivity of tumor cells to anti-cancer drugs that are activated by P450 enzymes. The use of bioreductive drugs that are activated by RED and/or cytochrome P450, in this paradigm, is also provided.

US Patent:

56887736, Nov 18, 1997

Filed:

Oct 28, 1994

Appl. No.:

8/330523

Inventors:

E. Antonio Chiocca - Boston MA
David J. Waxman - Newton Centre MA
Ming X. Wei - Somerville MA
Xandra O. Breakefield - Newton MA
Ling Chen - Brookline MA

Assignee:

The General Hospital Corporation - Boston MA
Boston University - Boston MA
Dana-Farber Cancer Institute - Boston MA

International Classification:

A61K 4800
C12N 500
C12N 1500
C07N 1400

US Classification:

514 44

Abstract:

A method for selectively killing nervous system and peripheral neoplastic cells is provided. Viral vectors are used to selectively express a cytochrome P450 gene in neoplastic cells, whose gene product targets the cells for selective killing, by rendering the cells sensitive to a chemotherapeutic agent.